Sourced from:Manufacturer Authorized Distributor
Quick Summary
Omalirel 150mg Injection
Last updated on 12 Oct 2026 | 05:05 AM (IST)
₹10601
MRP: ₹17494
(You Save ₹6893)
1 VIAL(s)
Sourced from:Manufacturer Authorized Distributor
Omalirel 150mg Injection
Salt Composition
OMALIZUMABMarketer
RELIANCE LIFE SCIENCES PVT LTD
Prepaid Only. Non-Returnable.
39% OFF
₹10601
MRP: ₹17,494.00
Inclusive of all taxes
39% Off
Salt Composition
OMALIZUMABMarketer
RELIANCE LIFE SCIENCES PVT LTD
Prepaid Only. Non-Returnable.
Dispatch: Today
Care delivered without the wait. Your order is prioritized for rapid dispatch to ensure it reaches your doorstep on time.
Substitutes
Emzumab 150mg Combikit Injection
CIPLA LTD
₹ 10266.00/injection
3% cheaper
Xolair 150mg Injection
NOVARTIS INDIA ...
₹ 26333.00/injection
149% costlier
Better Service Satisfied Customers
Introduction
Omalirel 150mg Injection contains omalizumab, a humanised monoclonal antibody that targets immunoglobulin E (IgE). It is used as an add-on treatment for certain allergic conditions, including moderate-to-severe persistent allergic asthma and chronic idiopathic urticaria.
Omalirel 150mg Injection is supplied as a lyophilised powder in a single-use vial for subcutaneous administration after reconstitution. The dose and frequency depend on the condition being treated and the patient's clinical requirements.
Omalizumab is a maintenance treatment and is not used for the immediate relief of an acute asthma attack.
Uses of Omalirel 150mg Injection
Omalirel 150mg Injection is used for:
Moderate-to-severe persistent allergic asthma: As an add-on treatment for eligible patients whose asthma is not adequately controlled with their existing treatment.
Chronic idiopathic urticaria: As an add-on treatment for patients who continue to have symptoms despite H1 antihistamine treatment.
The exact suitability, dose and treatment schedule are determined by the doctor based on the patient's condition.
How Omalirel 150mg Injection Works
Omalizumab binds to immunoglobulin E (IgE), an antibody involved in allergic inflammation.
By binding to circulating IgE, omalizumab reduces the amount of free IgE available to attach to IgE receptors on immune cells. This decreases IgE-mediated allergic inflammation and helps control symptoms associated with conditions in which IgE contributes to the disease process
Interaction of Omalirel 150mg Injection with Other Medicines
Tell your doctor about all prescription medicines, over-the-counter medicines, vitamins and herbal supplements you take.
Asthma medicines: Omalizumab is used as an add-on treatment. Continue your inhaled corticosteroids, bronchodilators and other prescribed asthma medicines unless your doctor advises otherwise.
Antihistamines: Omalizumab may be used alongside antihistamines for chronic idiopathic urticaria. Do not stop your antihistamine treatment without medical advice.
Other medicines: Tell your doctor about all medicines you use so that your overall treatment can be assessed appropriately.
No specific clinically significant medicine interaction is routinely expected with omalizumab. Your doctor will consider your complete treatment history before starting therapy.
Storage Conditions
Store Omalirel 150mg Injection in a refrigerator at 2°C to 8°C.
Do not freeze.
Keep the vial in its original packaging and protect it from light.
Keep it out of the reach and sight of children.
The reconstituted solution should be handled and stored according to the product-specific instructions provided with the medicine.
Omalirel 150mg Injection is supplied for single use. Discard any unused portion.
How to Use
Omalirel 150mg Injection is administered by subcutaneous injection after the lyophilised powder has been reconstituted.
The 150mg vial is reconstituted according to the product instructions before administration. The prescribed dose and frequency depend on the condition being treated.
For allergic asthma, the dose is determined according to the patient's baseline IgE concentration and body weight. Treatment may be given every 2 or 4 weeks depending on the prescribed dose.
For chronic idiopathic urticaria, the dose and frequency are determined by the treating doctor according to the patient's symptoms and response to treatment.
Omalirel should be administered by a healthcare professional who is prepared to recognise and manage serious allergic reactions. Do not change the prescribed dose or treatment frequency yourself.
Omalizumab does not provide immediate relief from an acute asthma attack. Continue to keep your prescribed reliever medicine available if you have asthma.
Safety Advice
Pregnancy
Tell your doctor if you are pregnant, planning to become pregnant or become pregnant during treatment. Your doctor will assess the potential benefits and risks of continuing omalizumab based on your individual condition.
Breast Feeding
Tell your doctor if you are breastfeeding before starting treatment. Discuss the potential benefits and risks of continuing treatment with your doctor.
Lungs
Omalirel is used to control certain forms of allergic asthma but does not provide immediate relief during an acute asthma attack. Continue your prescribed asthma medicines as directed and seek urgent medical attention for severe breathing difficulty.
Liver
Tell your doctor if you have liver disease before starting treatment. Your doctor will consider your medical history and determine whether any additional monitoring is required.
Alcohol
There is no specific alcohol interaction established with omalizumab. However, discuss alcohol consumption with your doctor, particularly if you have asthma or other medical conditions requiring regular treatment.
Driving
Omalizumab is not expected to directly affect your ability to drive. However, do not drive if you experience dizziness, fatigue or another symptom that affects your alertness.
Side Effects
Common side effects may include:
Injection-site reactions such as pain, redness, swelling or itching
Headache
Fever
Upper respiratory tract infection
Sinusitis
Joint pain
Dizziness
Abdominal pain
A serious allergic reaction called anaphylaxis can occur after omalizumab administration. Seek immediate medical attention if you develop:
Difficulty breathing or wheezing
Tightness in the throat or chest
Swelling of the throat or tongue
Difficulty swallowing
Severe dizziness or fainting
Hives or widespread itching
Rapid or weak heartbeat
Anaphylaxis can occur after the first dose or after subsequent doses. Omalirel should therefore be administered in a setting where appropriate treatment for a severe allergic reaction is available.
Expert Tips
Omalirel is a maintenance treatment and should not be used to treat a sudden asthma attack.
Continue your other prescribed asthma or allergy medicines unless your doctor advises you to stop them.
For allergic asthma, the dose is based on baseline IgE levels and body weight.
For chronic idiopathic urticaria, the dose is determined by your doctor based on your symptoms and treatment response.
Omalirel 150mg Injection is supplied as a lyophilised powder and must be reconstituted according to the product instructions before administration.
Do not attempt to prepare or administer the injection yourself unless your healthcare professional has specifically instructed and trained you to do so.
Tell your doctor if you have or are at risk of a parasitic infection, particularly if you live in or travel to an area where such infections are common.
Seek immediate medical attention if you develop symptoms of anaphylaxis after receiving the injection.
Do not stop your asthma or allergy treatment without consulting your doctor.
FAQs
Q1.
What is Omalirel 150mg Injection used for?
Omalirel 150mg Injection contains omalizumab and is used as an add-on treatment for eligible patients with moderate-to-severe persistent allergic asthma and chronic idiopathic urticaria.
Q2.
How does Omalirel 150mg Injection work?
Omalizumab binds to immunoglobulin E (IgE) and reduces the amount of free IgE in the blood. This decreases IgE-mediated allergic inflammation and helps control symptoms.
Q3.
How is Omalirel 150mg Injection administered?
Omalirel 150mg Injection is administered by subcutaneous injection after the lyophilised powder has been reconstituted according to the product instructions.
Q4.
Does the dose of Omalirel depend on body weight?
For allergic asthma, the dose of omalizumab is determined using the patient's baseline IgE concentration and body weight. The prescribed dose and frequency can therefore vary between patients.
Q5.
Can Omalirel 150mg Injection be used with other asthma medicines?
Yes. Omalizumab is used as an add-on treatment and may be prescribed alongside other asthma medicines. Do not stop your regular asthma treatment unless your doctor advises you to do so.
Q6.
Can Omalirel 150mg Injection be used for chronic idiopathic urticaria?
Yes. Omalizumab can be used as an add-on treatment for chronic idiopathic urticaria in patients who continue to have symptoms despite H1 antihistamine treatment.
Q7.
Can Omalirel 150mg Injection be used during pregnancy?
Tell your doctor if you are pregnant or planning a pregnancy. Your doctor will determine whether treatment should be continued based on your individual circumstances.
Q8.
Does Omalirel 150mg Injection need to be refrigerated?
Yes. Store Omalirel 150mg Injection at 2°C to 8°C and do not freeze it. Keep the vial protected from light and follow the product-specific instructions for the reconstituted solution.
Fact Box
Molecule name: | Omalizumab |
Therapeutic class: | Immunomodulator |
Pharmacological class: | Humanised monoclonal antibody |
Indications: | Moderate-to-severe persistent allergic asthma, chronic idiopathic urticaria |
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details

Written By
Naina Boruah
MSc Biomedical Science

Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 12 Oct 2026 | 05:05 AM (IST)

Want to know more?
Read Our Editorial Policy







